Reliable in use, removable when needed – Next-gen adhesive solutions that can be precisely and residue-free removedInnovation hub with impact – Accelerating customer-specific developments...
LINGSHUI, China, July 3, 2025 /PRNewswire/ -- The organizers of the HaiNan-Southeast Asia AI Hardware Battle (HNSE AHB) are pleased to announce an expanded prize...
PHILADELPHIA, PA, July 02, 2025 (GLOBE NEWSWIRE) -- Cohen Circle Acquisition Corp. II (NASDAQ:CCIIU) (the “Company”) today announced the closing of its initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $253,000,000.
The Global Outboard Motor Market is projected to grow from USD 5.75 billion in 2024 to USD 5.98 billion by 2033, driven by increasing recreational boating, marine transportation demand, and technological advances. Rising tourism and water sports popularity, along with a surge in the need for fuel-efficient outboard motors, are set to boost market growth globally. The market favors outboard motors due to their compact design, ease of maintenance, and efficiency. Key market players include Honda, Yamaha, and Mercury Marine, with significant growth expected in regions like North America, Europe, and emerging markets such as India and Saudi Arabia.
The Global Outboard Motor Market is projected to grow from USD 5.75 billion in 2024 to USD 5.98 billion by 2033, driven by increasing recreational boating, marine transportation demand, and technological advances. Rising tourism and water sports popularity, along with a surge in the need for fuel-efficient outboard motors, are set to boost market growth globally. The market favors outboard motors due to their compact design, ease of maintenance, and efficiency. Key market players include Honda, Yamaha, and Mercury Marine, with significant growth expected in regions like North America, Europe, and emerging markets such as India and Saudi Arabia.
Singapore, July 01, 2025 (GLOBE NEWSWIRE) -- Origin Investment Corp I (the “Company”), a blank check company, today announced the pricing of its initial public offering (“IPO”) of 6,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. The units are expected to begin trading on the Nasdaq Global Market (“Nasdaq”) on July 2, 2025 under the ticker symbol “ORIQU”. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as described in the prospectus. Only whole warrants are exercisable. The warrants will become exercisable 30 days after the completion of the Company’s initial business combination, and will expire five years after the completion of the Company’s initial business combination or earlier upon redemption or the Company’s liquidation. The offering is expected to close on July 3, 2025, subject to satisfaction of customary closing conditions. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be traded on Nasdaq under the symbols “ORIQ” and “ORIQW”, respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. In addition, the Company has granted the underwriters a 45-day option to purchase up to 900,000 additional units at the IPO price to cover over-allotments, if any.
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that on July 1, 2025, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 14,000 shares of the Company’s common stock to one (1) newly hired employee. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to such individual’s entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).
Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored by ANZUP, and supported by Bayer and...
Palo Alto, California, June 30, 2025 (GLOBE NEWSWIRE) -- NMP Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 10,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right. Each right entitles the holder to receive one-fifth (1/5) of one Class A ordinary share upon consummation of the Company’s initial business combination. In connection with the offering, $10.00 per unit will be deposited into a trust account with Continental Stock Transfer & Trust Company acting as trustee. Up to $300,000 of interest earned on the funds held in the trust account, in the aggregate, may be released to us to fund our working capital requirements. In addition, we may withdraw interest earned on the trust to pay our income and franchise taxes, if any. The units are expected to trade on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “NMPAU” beginning on July 1, 2025. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to trade on Nasdaq under the symbols “NMP” and “NMPAR,” respectively.